Development
Predictive Oncology Inc.
POAI
$0.9386
-$0.0114-1.20%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -3.16M | -3.92M | -3.42M | -7.92M | -4.06M |
| Total Depreciation and Amortization | 163.00K | 180.10K | 237.90K | 332.70K | 330.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 107.80K | 229.60K | 20.30K | 3.65M | 110.80K |
| Change in Net Operating Assets | -212.30K | -60.70K | -264.20K | 696.50K | 909.80K |
| Cash from Operations | -3.11M | -3.57M | -3.43M | -3.24M | -2.71M |
| Capital Expenditure | -3.90K | -255.40K | -24.40K | -58.00K | -128.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -3.70K | -22.30K | -5.60K | -15.30K |
| Cash from Investing | -3.90K | -259.10K | -46.60K | -63.60K | -143.70K |
| Total Debt Issued | 364.70K | -- | -- | -- | -- |
| Total Debt Repaid | -104.50K | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -23.60K | -4.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 260.20K | -- | -- | -23.60K | -4.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.85M | -3.83M | -3.47M | -3.32M | -2.86M |